Quince Therapeutics
QNCX
QNCX
41 hedge funds and large institutions have $12.5M invested in Quince Therapeutics in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Holders
41
Holding in Top 10
–
Calls
$96K
Puts
–
Top Buyers
| 1 | +$4.17M | |
| 2 | +$280K | |
| 3 | +$278K | |
| 4 |
USPCM
Union Square Park Capital Management
New York
|
+$199K |
| 5 |
Millennium Management
New York
|
+$183K |
Top Sellers
| 1 | -$606K | |
| 2 | -$245K | |
| 3 | -$198K | |
| 4 |
Morgan Stanley
New York
|
-$81.3K |
| 5 |
VF
Virtu Financial
New York
|
-$58K |
